论文成果
Improved response to nab-paclitaxel in combination with decitabine is independent of SPARC expression in NSCLC
发布时间：2021-11-19
- 所属单位： 生命科学学院
- 发表刊物： Journal of Thoracic Oncology
- 合写作者： Hylander B,Tan W,Adjei AA,Repasky E,Tang H,Salavaggione O,Yu C
- 通讯作者： Dy GK
- 卷号： 6
- 期号： 6
- 页面范围： 998-1005
- ISSN号： 1556-0864
- 是否译文： 否
- CN号： Roswell Park Cancer Institute
- 发表时间： 2011-06-15
上一条：Discovery of a Candidate Containing an (S)-3,3-Difluoro-1-(4- methylpiperazin-1-yl)-2,3-dihydro-1H-inden Scaffold as a Highly Potent Pan-Inhibitor of the BCR-ABL Kinase Including the T315I- Resistant Mutant for the Treatment of Chronic Myeloid Leukemia
下一条：Efficacy of focal adhesion kinase inhibition in non-small cell lung cancer with oncogenically activated MAPK pathways.